NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Biogen, along with some of the biggest names in the pharmaceutical industry, is investing in a new $100 million venture fund aimed at making new drugs and diagnostic tests available by 2025 to address the looming global health care problem of our time, Alzheimer’s disease. Jeremy Hunt, secretary of state…

news

Shanxi Zhendong Pharmaceutical Co Ltd says plans to acquire kangyuan pharmaceutical for 2.65 billion yuan ($416.82 million) via cash, share issue.   reuters.com

news

Beijing Science Sun Pharmaceutical Co Ltd says plans to set up industry buyout fund worth up to 800 million yuan ($125.87 million) with partners.   reuters.com

news

Strides Arcolab, an Indian drug manufacturer, has expanded its portfolio of offerings by acquiring brands from two companies in separate transactions. Strides signed a deal with Johnson & Johnson to buy seven of its brands in the dermatology, antiemetic and pain management segments. The portfolio acquired from J&J includes Otogesic…

news

Sprout Pharmaceuticals, Inc. (Sprout), a division of Valeant Pharmaceuticals North America LLC, announced that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women, is now available in the United States through certified physicians and pharmacies. Addyi was approved by the…

news

The Indian Patent Office has denied Germany's Boehringer Ingelheim a patent on its key HIV drug, Nevirapine, for a version sold as Viramune XR (extended release), yet again thwarting attempts by Big Pharma for "exclusivity" extension on their patented drugs to reportedly block entry of affordable generics. The application on…

news

PharMerica Corporation, a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, announced today that it has completed the acquisition of McGuire Group Pharmacy (“McGuire”). Terms of the transaction were not disclosed. McGuire provides comprehensive pharmacy services to long-term care facilities and other customers in the Buffalo-Niagara…

news

Indian drug maker Cipla has been served nine observations by the US FDA for its Indore-based manufacturing unit as part of an inspection that was conducted during July and August this year. The observations is a summary note of issues noticed by the FDA officials and needs corrections. Cipla remains…

news

More job-cutting pain is on the way at embattled Daiichi Sankyo. The Japan-based drugmaker will cut up to 1,200 jobs in the U.S., about half its workforce in its stateside subsidiary, Nikkei reports. The announcement follows a series of layoffs earlier this year at its Parsippany, NJ, operations. The cuts…

news

Valeant Pharmaceuticals International Inc (VRX.TO), which has been criticized for raising drug prices and is being investigated by the U.S. government, predicted on Monday that lower price increases are ahead for the whole industry. Valeant Chief Executive J. Michael Pearson told investors the company's 2016 outlook is based on expectations…